Appropriate fluid management in hospitalized patients remains a significant challenge for healthcare providers and is fundamental to achieving optimal clinical outcomes. In response, many healthcare systems have implemented fluid stewardship programs to better guide and standardize fluid administration.
As part of this strategy, a clear understanding of individual patient risk profiles is central to effective fluid management. Diabetes is a common comorbidity in patients admitted for a variety of diagnosis, affecting an estimated 12% of the population in the United States. Patients with this condition present unique and complex considerations in fluid management, which we will discuss here.
Pathophysiology of Fluid Imbalance in Diabetes
Diabetic patients are predisposed to dehydration secondary to osmotic diuresis, and also at heightened risk for electrolyte imbalances. Additionally, approximately 38% of adults with diabetes have chronic kidney disease (CKD), and further complicating this picture, 87% of those with CKD are unaware they have the diagnosis.
Patients with diabetes are particularly susceptible to osmotic diuresis due to persistent or episodic hyperglycemia. When plasma glucose concentrations exceed the renal threshold for glucose reabsorption (approximately 180 mg/dL), filtered glucose cannot be fully reabsorbed in the proximal tubules and is excreted in the urine.
The presence of glucose in the tubular lumen impairs water reabsorption and leads to increased urinary volume. This mechanism results in polyuria, with accompanying losses of free water and electrolytes, most notably sodium and potassium.
As a result, diabetic patients are at heightened risk for fluid imbalance, renal dysfunction, and hemodynamic instability, underscoring the importance of careful fluid assessment and management in this population.
Diabetes, Acute Kidney Injury and Accurate Assessment of Fluid Status
Fluid imbalances in diabetic patients have a direct impact on risk of developing acute kidney injury (AKI). It is well established that patients with diabetes are at increased risk of AKI compared to the general population. , This risk is further exacerbated in cases where there is a history, known or unknown, of CKD. Careful evaluation of volume status to proactively address developing AKI is essential. This assessment for hospitalized patients commonly includes parameters such as:
- Blood pressure
- Orthostatic changes
- Pulse rate
- Capillary refill time
- Mental status
- Skin turgor and perfusion
- Laboratory results (serum creatinine, blood lactate, sodium and urea excretion, SvO2 monitoring)
- Urine output
For these at-risk patients, KDIGO guidelines to identify AKI emphasize early identification through close monitoring of urine output and renal function. This approach defines AKI using changes in serum creatinine and/or urine output and recommends meticulous fluid management to support kidney perfusion.
The Important Role of Urine Output Monitoring for Diabetic Patients
In this context of increased risk of AKI, accurate urine output monitoring is critically important in hospitalized diabetic patients. Serum creatinine is a late indicator of AKI, but reduced urine output has been shown to predict AKI by as much as 46 hours earlier. Along with improved AKI detection, intensive urine output monitoring is also associated with improved outcomes, including reduced mortality.
Traditionally, manual urine output measurements have been the standard approach to monitoring this important vital sign. However, it is not without its limitations and is resource-intensive and prone to errors as well as missed and delayed measurements. More advanced approaches offer real-time, highly accurate measurements that exceed manual methods.
In critically ill patients, automated urine output monitoring is a crucial assessment tool. Research shows automated urine output monitoring is significantly more accurate than manual methods. With prompt, accurate identification of KDIGO AKI urine output criteria, clinicians are empowered to intervene sooner and improve outcomes.
Fluid Management Strategies in Diabetic Patients
In cases where diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemia state (HHS) have led to hypovolemia, fluid resuscitation should include intravenous fluid to restore the circulating intravascular volume, enhance tissue and organ perfusion, improve renal blood flow, and correct electrolyte abnormalities. Emerging science has highlighted the importance of individualized fluid replacement based on patient needs, alongside electrolyte replacement and insulin titration.,
It is important to strike a careful balance between correcting dehydration and avoiding fluid overload in vulnerable populations (e.g. patients who are elderly, pregnant, or have a history of end-stage renal disease, advanced liver disease, or heart failure).
Summary and Clinical Implications
Fluid management in hospitalized patients with diabetes requires careful integration of pathophysiologic understanding, risk stratification, and ongoing clinical assessment. The high prevalence of osmotic diuresis, unrecognized chronic kidney disease, and increased susceptibility to acute kidney injury underscores the need for vigilant monitoring and individualized fluid strategies in this population.
Accurate assessment of volume status—particularly through timely urine output monitoring—plays a critical role in early AKI detection and guides safer clinical decision‑making. Advances in automated urine output monitoring further enhance precision and facilitate earlier intervention. Ultimately, optimizing fluid therapy in diabetic patients depends on balancing effective resuscitation with avoidance of fluid overload, informed by continuous reassessment and adherence to evidence‑based principles.
References
- https://gis.cdc.gov/grasp/diabetes/diabetesatlas-statsreport.html
- https://www.japi.org/article/japi-72-6-s1-16
- https://www.cdc.gov/kidney-disease/php/data-research/index.html#
- https://www.africanjournalofdiabetesmedicine.com/articles/understanding-the-renal-threshold-for-glucose-implications-for-diabetes-management-109985.html
- https://www.rcemlearning.co.uk/modules/diabetic-ketoacidosis/lessons/basic-science-and-pathophysiology-42/topic/osmotic-diuresis/
- https://www.mdpi.com/2673-4540/6/12/148
- https://pmc.ncbi.nlm.nih.gov/articles/PMC10219694/
- https://www.sciencedirect.com/science/article/pii/S0085253815558560#
- https://kdigo.org/wp-content/uploads/2026/03/KDIGO-2026-AKI-AKD-Guideline-Public-Review-Draft-March-2026.pdf
- https://pmc.ncbi.nlm.nih.gov/articles/PMC11233478/#
- https://journal.chestnet.org/article/S0012-3692(17)30933-9/fulltext
- https://www.nature.com/articles/s41598-021-97026-8
- https://diabetesjournals.org/care/article/47/8/1257/156808/Hyperglycemic-Crises-in-Adults-With-Diabetes-A
- https://www.kidneynews.org/view/journals/kidney-news/17/7/article-p25_18.xml
- https://www.bmj.com/content/365/bmj.l1114
